Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · IEX Real-Time Price · USD
3.325
+0.005 (0.15%)
Jun 25, 2024, 2:39 PM EDT - Market open

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $35.30M in the twelve months ending March 31, 2024, with 35.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.97M with 50.19% year-over-year growth. In the year 2023, Eton Pharmaceuticals had annual revenue of $32.64M with 42.60% growth.

Revenue (ttm)
$35.30M
Revenue Growth
+35.69%
P/S Ratio
2.45
Revenue / Employee
$1,176,800
Employees
30
Market Cap
86.52M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202332.64M9.75M42.60%
Dec 31, 202222.89M-441.00K-1.89%
Dec 31, 202123.33M23.29M59,725.64%
Dec 31, 202039.00K-920.00K-95.93%
Dec 31, 2019959.00K--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.05B
PetMed Express 281.06M
SHL Telemedicine 57.08M
ProPhase Labs 28.72M
Forian 20.49M
Gritstone bio 15.65M
VistaGen Therapeutics 1.06M
Revenue Rankings